Goldman Sachs Upgrades Incyte (INCY) to Neutral

October 31, 2014 7:20 AM

Goldman Sachs upgraded Incyte (NASDAQ: INCY) from Sell to Neutral with a price target of $62.00 (from $32.00).Analyst Navdeep Singh ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found